News for hackers. Stuff that matters.
Re:Psilocybin for treatment-resistant depression: fMRI-measu... by gwern on Saturday October 14, 2017 @09:53AM (#15472171)
I believe the ketamine anti-depressant experiments use a different anesthetic to put subjects under in order to split the trip experience from the lower-level chemical effects, and still find benefits. If the trip itself is not necessary for ketamine, that makes it more plausible that it's not necessary for psilocybin etc.

(Of course, this doesn't rule out the possibility that much of the benefit is coming from after the trip during regular life based on experiencing regular life with 'reset' neurons under the Carhart-Harris/Nutt interpretation.)

Re:Psilocybin for treatment-resistant depression: fMRI-measu... by bramen on Saturday October 14, 2017 @03:28PM (#15473754)
The experiments I've read about don't use any additional anaesthetic. They just give people a low but still noticeable dose intravenously. Some people reported mild and transient unpleasantness during the treatment due to the drug's effects.
Re:Psilocybin for treatment-resistant depression: fMRI-measu... by amigoingtodie on Saturday October 14, 2017 @10:43AM (#15472366)
Ketamine is used as a disassociative, though.
Re:Psilocybin for treatment-resistant depression: fMRI-measu... by pizza on Saturday October 14, 2017 @08:47PM (#15475191)
The categories aren't necessarily as clear cut as label -> effect, though, as in psychedelics (including psilocybin and its relatives) can be dissociating, and ketamine (and other dissociatives) can be psychedelic. That said, not because of particularly similar physiology; they certainly have different receptor targets.